In 2009, thunderclap: the Center for Disease Control and Prevention (CDC), the US health agency, said in a memo that the vaccine against human papillomavirus presented a risk of phlebitis.
This pathology corresponds to the formation of a blood clot (called a “thrombus”) in an artificial or deep vein. The result is blood circulation difficulties, from edemaor even pulmonary embolism.
But a recent American study (published in the Journal of the American Medical Association) sweeps away fears: after observing 500,000 girls and women aged 10 to 44 who were vaccinated against the human papillomavirus (HPV) between 2006 and 2013, the researchers concluded that the papillomavirus vaccine (which notably prevents the Cervical cancer) did not cause phlebitis.
No blood clots
The patients were followed up to 42 days after the administration of the vaccine: in the end, only 4,375 people (out of 500,000, so less than 5%) developed blood clots, but these were due to the contraceptive pill taken. by patients. The pill is indeed well known to cause phlebitis.
No risk, therefore, of developing a blood circulation disorder after being vaccinated. Remember that the papillomavirus is transmitted genitally, that it affects both men and women and that it exists in nearly 150 different forms. The National Institute for Health Watch (INVS) estimates that 80% of women are exposed to it at least once in their life …
And you, have you been vaccinated against the papillomavirus? Have you planned to vaccinate your daughter? We talk on the forum.
